Skip to content

Author

Emil Sergejuk

We have 3 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

LEFT ATRIAL MECHANICS ASSESSED BY SPECKLE-TRACKING ECHOCARDIOGRAPHY IN ADULT PATIENTS UNDERGOING HEMODIALYSIS: A SYSTEMATIC REVIEW

Left atrial strain may serve as a sensitive imaging biomarker of subclinical cardiovascular dysfunction and may improve cardiovascular risk stratification in this population, however, further prospective multicenter studies are required to standardize methodology and confirm the role of left atrial strain in routine cl...

T. Mainka, Emil Sergejuk, W. Kotlarski et al. · 0 citations
Review Open access Aug 2026

DIASTOLIC DYSFUNCTION AS AN EARLY INDICATOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW

Diastolic dysfunction appears to be a clinically relevant and potentially early marker of anthracycline-induced cardiotoxicity in breast cancer patients, and earlier recognition may support closer cardio-oncology surveillance, improve risk stratification, and help identify patients who may benefit from earlier speciali...

T. Mainka, Emil Sergejuk, W. Kotlarski et al. · 0 citations
Review Open access Aug 2026

LEFT VENTRICULAR GLOBAL LONGITUDINAL STRAIN FOR EARLY DETECTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN ADULT BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW

LV GLS appears to be a sensitive and clinically useful echocardiographic marker for the early detection of anthracycline-induced cardiotoxicity in adult breast cancer patients and may improve identification of subclinical cardiac dysfunction before a measurable decline in left ventricular ejection fraction occurs.

T. Mainka, Emil Sergejuk, W. Kotlarski et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.